Immunic, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.09 | -100% | -4.1 | -100% |
| P/S |
|
0 | 33.5 | -100% |
|
|
| P/BV |
|
2.21 | 4.61 | -52.19% |
|
|
| P/FCF |
|
-1.01 | 39.71 | -102.54% |
|
|
| Ev/Ebitda |
|
-0.1865 | -19.46 | -99.04% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-0.2597 | 45.47 | -100.57% |
|
|
| E/P |
|
-1.3 | 0.0164 | -8051.07% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -14.42 | -100% | -163170.83 | -100% |
| ROE |
|
-323.57 | 9.01 | -3691.07% |
|
|
| ROA |
|
-172.4 | 0.0151 | -1138455.64% |
|
|
| ROIC |
|
-57.1 | 7.63 | -847.93% |
|
|
| ROS |
|
0 | -26.5 | -100% |
|
|
| ROCE |
|
-342.96 | 13.75 | -2593.72% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0135 | -3.73 | -99.64% | -0.0119 | +12.65% |
| Nеt Debt/Ebitda |
|
0.4575 | -3.19 | -114.33% |
|
|
| Debt/Ratio |
|
0.0246 | 0.1777 | -86.18% |
|
|
| Debt/Equity |
|
4.54 | 1.57 | 188.72% |
|
|
| Debt/Net Income |
|
-0.0143 | 0.8429 | -101.69% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 73.67 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
168 | 15.28 | 999.48% | ||
| Growth impulse Net Income in 5 years |
|
167.46 | -33.08 | -606.23% | ||
| Growth impulse FCF in 5 years |
|
145.39 | -6.99 | -2179.97% | ||
| Growth impulse EPS in 5 years |
|
-53.27 | -59.11 | -9.88% |
IP Score
3.52/10
